Skip to main content

High Impact Hepatology: Updates from the Major Liver Meetings

December 5, 2020, Virtual

Target Audience

Physicians, Fellows, Residents, Physician Assistants, Nurses/Nurse Practitioners, and Pharmacists.

Learning Objectives

At the conclusion of the knowledge-based activity, the learner should be able to:

  1. Discuss the real world evidence on the natural history of viral hepatitis and chronic liver disease.
  2. Identify the success and limitations of treatment modalities for autoimmune hepatitis and cholestatic liver disease.
  3. Discuss the currently available treatment options for patients with NASH.
  4. Review new concepts in the management of complications of end-stage liver disease, including the management of portal hypertension, hepatic encephalopathy, and hepatocellular carcinoma.